Quick answer
MIRACQ is a multi-channel intraoperative collaboration and quality-control robot developed by Beijing Anzhen Hospital with Beihang University and partners. It does not operate on its own: it plans the operation, watches the field, flags anomalies and transmits a synchronised multi-modal record to a remote command centre, where experienced surgeons at Anzhen can guide several operations at once. It has supported more than 25,000 operations, with zero deaths among cases under command-centre coverage [1][2][3].
Key takeaways
- Developed by Anzhen with Beihang University and others; described as the world's first multi-channel intraoperative collaboration and quality-control robot [2][4].
- Functions: pre-operative planning, intraoperative anomaly alerts, automatic surgical-field tracking, full recording, multi-device data fusion and remote transmission [1].
- Signal latency is compressed to under 200 ms by bundling 5G, 4G and wired links [2].
- Deployed in Qinghai and Yunnan and at 10-plus centres; has Class II device registration and a production licence [1][3].
- Anzhen's remote command centre lets experts guide multiple operations simultaneously [1].
What the system does
Cardiac surgery is unforgiving of small errors — a mis-step near the left ventricular posterior wall during mitral valve work can become a fatal rupture within seconds. MIRACQ's answer is not autonomy but supervision: a robot-mounted camera that never loses the field, a record that captures every device's data on one timeline, and a remote expert who can see it all [2].
The hardware reflects that job. A self-developed three-degree-of-freedom arm with radar ranging and AI field-tracking re-aims itself when the surgeon's head or an instrument blocks the view; it reaches 1.8 m, zooms 25× and returns 4K/1080P images. Data from DSA, ultrasound, IVUS, OCT and endoscopy are aligned to one clock to form a "surgical black box" for review and teaching [2].
The remote model
The point of all that data is distance. Anzhen's command centre receives the stream and lets a senior surgeon watch and advise while the operating team works locally. In one reported case a 61-year-old man in Baoshan, Yunnan, underwent mitral valve replacement with Beijing specialists monitoring throughout [4].
The programme has spread to Qinghai and other highland and border regions, where local teams can attempt complex cardiac cases that would otherwise require travelling thousands of kilometres [1].
The condition in context: cardiac surgery access in China
China performs a very large volume of cardiac surgery, but expertise is concentrated in eastern metropolitan centres.
| Region | What the data shows | Source |
|---|---|---|
| China | About 12 million people have heart failure, with 500,000–600,000 in end-stage disease needing transplant or a device [5]. | Xinhua interview [5] |
| Aortic dissection | Chinese operative mortality for aortic dissection is below the international average of 15–24% [5]. | Xinhua interview [5] |
| Equity | Remote guidance lets highland and border hospitals attempt cases they would otherwise refer out [1]. | Xinhua [1] |
The gap that remote quality control targets is not equipment but judgement — the intraoperative decisions that separate an experienced cardiac surgeon from a capable general one [1][2].
Why it matters
| Potential | What the report suggests | Source |
|---|---|---|
| Safety | Zero mortality among command-centre-covered cases; overall mortality 0.39% in the developer's summary [1][3]. | [1][3] |
| Access | Remote guidance brings complex surgery to under-served regions [1][4]. | [1][4] |
| Caution | Zero-mortality coverage is a selected, monitored subset, not proof that the robot causes better outcomes [3]. | [3] |
Availability and limits
- This is an editorial summary of hospital, conference and media reports, not an independent clinical trial [1][2][3].
- MIRACQ supports and records surgery; it does not perform the operation autonomously [2].
- The zero-mortality figure covers operations under command-centre supervision, a selected group [3].
- Deployment outside China and availability to international patients are not described [1].
- Heart-failure prevalence figures come from an interview, not a registry [5].
What to ask before booking
| Question | Why it matters |
|---|---|
| Will my operation be under remote expert supervision? | The reported safety figures apply to command-centre-covered cases [3]. |
| Who is the primary surgeon, and what is their volume for my procedure? | Remote guidance supplements, not replaces, local surgical skill [1]. |
| Which department handles foreign patients, and in what language? | Anzhen is a working hospital we do not book; confirm international-department coordination and language support. |
| What is the cost and recovery pathway? | Cardiac surgery costs vary widely by procedure [5]. |
Questions patients ask
What is MIRACQ?
A multi-channel intraoperative collaboration and quality-control robot developed by Beijing Anzhen Hospital with Beihang University and partners; it plans, monitors, records and streams surgery to a remote command centre [1][2].
Does the robot operate by itself?
No. It supports the surgical team with planning, field tracking, alerts, recording and remote transmission; the surgeon operates [2].
How many operations has it supported?
More than 25,000, with zero deaths among cases under command-centre coverage and overall mortality of 0.39% in the developer's summary [1][3].
Where is it deployed?
At 10-plus centres including Qinghai and Yunnan, with Class II device registration and a production licence [1][3].
Is this relevant to international patients?
It is useful context for China's cardiac-surgery capability. Anzhen is a working hospital we do not book — contact its international department directly [1][2].